These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21385923)

  • 21. No evidence for genetic association with the let-7 microRNA-binding site or other common KRAS variants in risk of endometriosis.
    Luong HT; Nyholt DR; Painter JN; Chapman B; Kennedy S; Treloar SA; Zondervan KT; Montgomery GW
    Hum Reprod; 2012 Dec; 27(12):3616-21. PubMed ID: 23010532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
    Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
    Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
    Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
    PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.
    Kjersem JB; Ikdahl T; Guren T; Skovlund E; Sorbye H; Hamfjord J; Pfeiffer P; Glimelius B; Kersten C; Solvang H; Tveit KM; Kure EH
    BMC Cancer; 2012 Nov; 12():534. PubMed ID: 23167843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
    Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
    Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer.
    Wang C; Guo Z; Wu C; Li Y; Kang S
    Cancer Genet; 2012; 205(7-8):373-6. PubMed ID: 22867998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
    Christensen BC; Moyer BJ; Avissar M; Ouellet LG; Plaza SL; McClean MD; Marsit CJ; Kelsey KT
    Carcinogenesis; 2009 Jun; 30(6):1003-7. PubMed ID: 19380522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
    Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PD; ; ; ; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; deFazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1421-7. PubMed ID: 24740199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
    Phelan CM; Kuchenbaecker KB; Tyrer JP; Kar SP; Lawrenson K; Winham SJ; Dennis J; Pirie A; Riggan MJ; Chornokur G; Earp MA; Lyra PC; Lee JM; Coetzee S; Beesley J; McGuffog L; Soucy P; Dicks E; Lee A; Barrowdale D; Lecarpentier J; Leslie G; Aalfs CM; Aben KKH; Adams M; Adlard J; Andrulis IL; Anton-Culver H; Antonenkova N; ; Aravantinos G; Arnold N; Arun BK; Arver B; Azzollini J; Balmaña J; Banerjee SN; Barjhoux L; Barkardottir RB; Bean Y; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Birrer MJ; Bjorge L; Black A; Blankstein K; Blok MJ; Bodelon C; Bogdanova N; Bojesen A; Bonanni B; Borg Å; Bradbury AR; Brenton JD; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Bruinsma F; Brunet J; Buecher B; Butzow R; Buys SS; Caldes T; Caligo MA; Campbell I; Cannioto R; Carney ME; Cescon T; Chan SB; Chang-Claude J; Chanock S; Chen XQ; Chiew YE; Chiquette J; Chung WK; Claes KBM; Conner T; Cook LS; Cook J; Cramer DW; Cunningham JM; D'Aloisio AA; Daly MB; Damiola F; Damirovna SD; Dansonka-Mieszkowska A; Dao F; Davidson R; DeFazio A; Delnatte C; Doheny KF; Diez O; Ding YC; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dossus L; Duran M; Dürst M; Dworniczak B; Eccles D; Edwards T; Eeles R; Eilber U; Ejlertsen B; Ekici AB; Ellis S; Elvira M; ; Eng KH; Engel C; Evans DG; Fasching PA; Ferguson S; Ferrer SF; Flanagan JM; Fogarty ZC; Fortner RT; Fostira F; Foulkes WD; Fountzilas G; Fridley BL; Friebel TM; Friedman E; Frost D; Ganz PA; Garber J; García MJ; Garcia-Barberan V; Gehrig A; ; Gentry-Maharaj A; Gerdes AM; Giles GG; Glasspool R; Glendon G; Godwin AK; Goldgar DE; Goranova T; Gore M; Greene MH; Gronwald J; Gruber S; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harrington PA; Harris HR; Hauke J; ; Hein A; Henderson A; Hildebrandt MAT; Hillemanns P; Hodgson S; Høgdall CK; Høgdall E; Hogervorst FBL; Holland H; Hooning MJ; Hosking K; Huang RY; Hulick PJ; Hung J; Hunter DJ; Huntsman DG; Huzarski T; Imyanitov EN; Isaacs C; Iversen ES; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jernetz M; Jensen A; Jensen UB; John EM; Johnatty S; Jones ME; Kannisto P; Karlan BY; Karnezis A; Kast K; ; Kennedy CJ; Khusnutdinova E; Kiemeney LA; Kiiski JI; Kim SW; Kjaer SK; Köbel M; Kopperud RK; Kruse TA; Kupryjanczyk J; Kwong A; Laitman Y; Lambrechts D; Larrañaga N; Larson MC; Lazaro C; Le ND; Le Marchand L; Lee JW; Lele SB; Leminen A; Leroux D; Lester J; Lesueur F; Levine DA; Liang D; Liebrich C; Lilyquist J; Lipworth L; Lissowska J; Lu KH; Lubinński J; Luccarini C; Lundvall L; Mai PL; Mendoza-Fandiño G; Manoukian S; Massuger LFAG; May T; Mazoyer S; McAlpine JN; McGuire V; McLaughlin JR; McNeish I; Meijers-Heijboer H; Meindl A; Menon U; Mensenkamp AR; Merritt MA; Milne RL; Mitchell G; Modugno F; Moes-Sosnowska J; Moffitt M; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Nathanson KL; Nedergaard L; Ness RB; Neuhausen SL; Nevanlinna H; Niederacher D; Nussbaum RL; Odunsi K; Olah E; Olopade OI; Olsson H; Olswold C; O'Malley DM; Ong KR; Onland-Moret NC; ; Orr N; Orsulic S; Osorio A; Palli D; Papi L; Park-Simon TW; Paul J; Pearce CL; Pedersen IS; Peeters PHM; Peissel B; Peixoto A; Pejovic T; Pelttari LM; Permuth JB; Peterlongo P; Pezzani L; Pfeiler G; Phillips KA; Piedmonte M; Pike MC; Piskorz AM; Poblete SR; Pocza T; Poole EM; Poppe B; Porteous ME; Prieur F; Prokofyeva D; Pugh E; Pujana MA; Pujol P; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Rhiem K; Rice P; Richardson A; Robson M; Rodriguez GC; Rodríguez-Antona C; Romm J; Rookus MA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Salvesen HB; Sandler DP; Schoemaker MJ; Senter L; Setiawan VW; Severi G; Sharma P; Shelford T; Siddiqui N; Side LE; Sieh W; Singer CF; Sobol H; Song H; Southey MC; Spurdle AB; Stadler Z; Steinemann D; Stoppa-Lyonnet D; Sucheston-Campbell LE; Sukiennicki G; Sutphen R; Sutter C; Swerdlow AJ; Szabo CI; Szafron L; Tan YY; Taylor JA; Tea MK; Teixeira MR; Teo SH; Terry KL; Thompson PJ; Thomsen LCV; Thull DL; Tihomirova L; Tinker AV; Tischkowitz M; Tognazzo S; Toland AE; Tone A; Trabert B; Travis RC; Trichopoulou A; Tung N; Tworoger SS; van Altena AM; Van Den Berg D; van der Hout AH; van der Luijt RB; Van Heetvelde M; Van Nieuwenhuysen E; van Rensburg EJ; Vanderstichele A; Varon-Mateeva R; Vega A; Edwards DV; Vergote I; Vierkant RA; Vijai J; Vratimos A; Walker L; Walsh C; Wand D; Wang-Gohrke S; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; Whittemore AS; Wijnen JT; Wilkens LR; Wolk A; Woo M; Wu X; Wu AH; Yang H; Yannoukakos D; Ziogas A; Zorn KK; Narod SA; Easton DF; Amos CI; Schildkraut JM; Ramus SJ; Ottini L; Goodman MT; Park SK; Kelemen LE; Risch HA; Thomassen M; Offit K; Simard J; Schmutzler RK; Hazelett D; Monteiro AN; Couch FJ; Berchuck A; Chenevix-Trench G; Goode EL; Sellers TA; Gayther SA; Antoniou AC; Pharoah PDP
    Nat Genet; 2017 May; 49(5):680-691. PubMed ID: 28346442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
    Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
    Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Let-7 microRNA-binding-site polymorphism in the 3'UTR of KRAS and colorectal cancer outcome: a systematic review and meta-analysis.
    Langevin SM; Christensen BC
    Cancer Med; 2014 Oct; 3(5):1385-95. PubMed ID: 24890702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
    Song H; Dicks E; Ramus SJ; Tyrer JP; Intermaggio MP; Hayward J; Edlund CK; Conti D; Harrington P; Fraser L; Philpott S; Anderson C; Rosenthal A; Gentry-Maharaj A; Bowtell DD; Alsop K; Cicek MS; Cunningham JM; Fridley BL; Alsop J; Jimenez-Linan M; Høgdall E; Høgdall CK; Jensen A; Kjaer SK; Lubiński J; Huzarski T; Jakubowska A; Gronwald J; Poblete S; Lele S; Sucheston-Campbell L; Moysich KB; Odunsi K; Goode EL; Menon U; Jacobs IJ; Gayther SA; Pharoah PD
    J Clin Oncol; 2015 Sep; 33(26):2901-7. PubMed ID: 26261251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular diagnosis in type I epithelial ovarian cancer.
    Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
    Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
    Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
    Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential for risk stratification in the management of ovarian cancer risk.
    Pharoah PD
    Int J Gynecol Cancer; 2012 May; 22 Suppl 1():S16-7. PubMed ID: 22543912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
    Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
    Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
    Permuth-Wey J; Lawrenson K; Shen HC; Velkova A; Tyrer JP; Chen Z; Lin HY; Chen YA; Tsai YY; Qu X; Ramus SJ; Karevan R; Lee J; Lee N; Larson MC; Aben KK; Anton-Culver H; Antonenkova N; Antoniou AC; Armasu SM; ; ; Bacot F; Baglietto L; Bandera EV; Barnholtz-Sloan J; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Cai Q; Campbell I; Chang-Claude J; Chanock S; Chenevix-Trench G; Cheng JQ; Cicek MS; Coetzee GA; ; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; du Bois A; Dürst M; Easton DF; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher DA; Flanagan JM; Garcia-Closas M; Gentry-Maharaj A; Giles GG; Glasspool RM; Gonzalez-Bosquet J; Goodman MT; Gore M; Górski B; Gronwald J; Hall P; Halle MK; Harter P; Heitz F; Hillemanns P; Hoatlin M; Høgdall CK; Høgdall E; Hosono S; Jakubowska A; Jensen A; Jim H; Kalli KR; Karlan BY; Kaye SB; Kelemen LE; Kiemeney LA; Kikkawa F; Konecny GE; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Lancaster JM; Le ND; Leminen A; Levine DA; Liang D; Lim BK; Lin J; Lissowska J; Lu KH; Lubiński J; Lurie G; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Menon U; Modugno F; Moysich KB; Nakanishi T; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Noushmehr H; Odunsi K; Olson SH; Orlow I; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Raska P; Renner SP; Risch HA; Rodriguez-Rodriguez L; Rossing MA; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schwaab I; Severi G; Shridhar V; Shu XO; Shvetsov YB; Sieh W; Song H; Southey MC; Spiewankiewicz B; Stram D; Sutphen R; Teo SH; Terry KL; Tessier DC; Thompson PJ; Tworoger SS; van Altena AM; Vergote I; Vierkant RA; Vincent D; Vitonis AF; Wang-Gohrke S; Palmieri Weber R; Wentzensen N; Whittemore AS; Wik E; Wilkens LR; Winterhoff B; Woo YL; Wu AH; Xiang YB; Yang HP; Zheng W; Ziogas A; Zulkifli F; Phelan CM; Iversen E; Schildkraut JM; Berchuck A; Fridley BL; Goode EL; Pharoah PD; Monteiro AN; Sellers TA; Gayther SA
    Nat Commun; 2013; 4():1627. PubMed ID: 23535648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
    Plaskocinska I; Shipman H; Drummond J; Thompson E; Buchanan V; Newcombe B; Hodgkin C; Barter E; Ridley P; Ng R; Miller S; Dann A; Licence V; Webb H; Tan LT; Daly M; Ayers S; Rufford B; Earl H; Parkinson C; Duncan T; Jimenez-Linan M; Sagoo GS; Abbs S; Hulbert-Williams N; Pharoah P; Crawford R; Brenton JD; Tischkowitz M
    J Med Genet; 2016 Oct; 53(10):655-61. PubMed ID: 27208206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
    Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A targeted genetic association study of epithelial ovarian cancer susceptibility.
    Earp M; Winham SJ; Larson N; Permuth JB; Sicotte H; Chien J; Anton-Culver H; Bandera EV; Berchuck A; Cook LS; Cramer D; Doherty JA; Goodman MT; Levine DA; Monteiro AN; Ness RB; Pearce CL; Rossing MA; Tworoger SS; Wentzensen N; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Cunningham JM; Edwards RP; Fogarty ZC; Iversen ES; Kraft P; Larson MC; Le ND; Lin HY; Lissowska J; Modugno F; Moysich KB; Olson SH; Pike MC; Poole EM; Rider DN; Terry KL; Thompson PJ; van den Berg D; Vierkant RA; Vitonis AF; Wilkens LR; Wu AH; Yang HP; Ziogas A; Phelan CM; Schildkraut JM; Chen YA; Sellers TA; Fridley BL; Goode EL
    Oncotarget; 2016 Feb; 7(7):7381-9. PubMed ID: 26848776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.